Q1 2017 Holdings
Filed 2017-05-15 | 55 holdings | $47.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Angiodynamics Inc(ANGO) | COM | 03475V101 | $25.4M | 1,465,452 | 53.3% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $16.0M | 8,200,000 | 33.5% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $5.0M | 1,028,672 | 10.5% |
| Alphatec Holdings Inc(ATEC) | COM NEW | 02081G201 | $527.0K | 226,006 | 1.1% |
| Horizon Pharma PLC | SHS | G4617B105 | $83.7K | 5,664,219 | 0.2% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $74.2K | 4,947,403 | 0.2% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $69.3K | 1,000,000 | 0.1% |
| Retrophin Inc | COM | 761299106 | $53.4K | 2,892,178 | 0.1% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $42.5K | 4,394,464 | 0.1% |
| Recro Pharma Inc | COM | 75629F109 | $27.1K | 3,100,086 | 0.1% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $23.4K | 782,887 | 0.0% |
| Ignyta Inc | COM | 451731103 | $22.7K | 2,637,346 | 0.0% |
| Endo Intl PLCCall | SHS | G30401106 | $22.3K | 2,000,000 | 0.0% |
| Antares Pharma Inc(ATRSEUR) | COM | 036642106 | $21.7K | 7,642,206 | 0.0% |
| Endo Intl PLC | SHS | G30401106 | $21.0K | 1,883,738 | 0.0% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $20.9K | 1,948,554 | 0.0% |
| Aratana Therapeutics Inc(PETXEUR) | COM | 03874P101 | $19.6K | 3,695,442 | 0.0% |
| Progenics Pharmaceuticals in | COM | 743187106 | $18.9K | 1,998,531 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $18.7K | 2,509,059 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $15.1K | 1,648,566 | 0.0% |
| Teligent Inc New | COM | 87960W104 | $15.1K | 1,931,711 | 0.0% |
| Horizon Pharma PLCCall | SHS | G4617B105 | $14.8K | 1,000,000 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $14.2K | 2,981,706 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $12.4K | 1,519,259 | 0.0% |
| Endologix Inc | COM | 29266S106 | $12.1K | 1,669,020 | 0.0% |
| Corium Intl Inc | COM | 21887L107 | $11.7K | 2,787,121 | 0.0% |
| Aralez Pharmaceuticals Inc | COM | 03852X100 | $11.1K | 5,191,590 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $10.9K | 2,090,801 | 0.0% |
| Medicines Co | COM | 584688105 | $10.5K | 215,077 | 0.0% |
| Biodelivery Sciences Intl in(BDSIUSD) | COM | 09060J106 | $10.3K | 5,398,794 | 0.0% |
| Idera Pharmaceuticals Inc | COM NEW | 45168K306 | $9.5K | 3,852,945 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $9.1K | 2,833,649 | 0.0% |
| Durect Corp(DRRXEUR) | COM | 266605104 | $8.9K | 8,506,229 | 0.0% |
| Seaspine Hldgs Corp(SPNEUSD) | COM | 81255T108 | $8.6K | 1,099,807 | 0.0% |
| Egalet Corp | NOTE 5.500% 4/0 | 28226BAB0 | $8.2K | 10,000,000 | 0.0% |
| Bard C R Inc(BCRUSD) | COM | 067383109 | $6.8K | 27,300 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $4.4K | 562,875 | 0.0% |
| Nexvet Biopharma PUB LTD Co | ORD SHS | G6503X109 | $4.4K | 1,127,200 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $4.3K | 223,862 | 0.0% |
| Mediwound LTD | ORD SHS | M68830104 | $4.2K | 633,102 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $4.2K | 49,300 | 0.0% |
| Scynexis Inc | COM | 811292101 | $4.1K | 1,477,273 | 0.0% |
| Pernix Therapeutics Hldgs in | DBCV 4.250% 4/0 | 71426VAK4 | $4.0K | 15,500,000 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $3.9K | 175,700 | 0.0% |
| Oncomed Pharmaceuticals IncCall | COM | 68234X102 | $2.8K | 300,000 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $2.6K | 1,429,109 | 0.0% |
| Progenics Pharmaceuticals inCall | COM | 743187106 | $2.4K | 250,000 | 0.0% |
| Aviragen Therapeutics Inc | COM | 053761102 | $2.1K | 3,179,226 | 0.0% |
| Alcobra LTD | SHS | M2239P109 | $1.4K | 1,216,643 | 0.0% |
| Cogentix MED Inc | COM | 19243A104 | $1.4K | 753,773 | 0.0% |